Biology of Young Lung Cancer Study: The YOUNG LUNG Study
Status: Recruiting
Location: See all (4) locations...
Intervention Type: Genetic
Study Type: Observational
SUMMARY
The purpose of this research study is to learn more about lung cancer (NSCLC or SCLC) diagnosed in adults at ages 45 or younger.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 15
Healthy Volunteers: f
View:
• Age 45 and under at lung cancer diagnosis
• Pathologically confirmed bronchogenic lung carcinoma (NSCLC or SCLC of any stage) at any treatment time point
• Provision of written informed consent
• Willingness to undergo no more than two (2) peripheral blood draws in a four (4) week period, with no more than 50 ml peripheral blood collected over eight (8) weeks
• Individuals under age 18 are eligible for study if they meet defined criteria; in addition, consent for participation must be given by a legal guardian or parent
Locations
United States
Massachusetts
Beth Israel Deaconess Medical Center
NOT_YET_RECRUITING
Boston
Brigham and Women's Hospital
NOT_YET_RECRUITING
Boston
Dana-Farber Cancer Institute
RECRUITING
Boston
Massachusetts General Hospital
RECRUITING
Boston
Contact Information
Primary
Pasi A Janne, MD, PhD
Pasi_Janne@dfci.harvard.edu
617-632-6036
Time Frame
Start Date: 2023-01-01
Estimated Completion Date: 2027-08-01
Participants
Target number of participants: 500
Treatments
Data/Biospecimen Collection
Tumor and saliva specimens from participants with non-small cell lung cancer (NSCLC) or small cell lung cancer (SCLC) diagnosed at age 45 or younger
Related Therapeutic Areas
Sponsors
Leads: Dana-Farber Cancer Institute